Citius Oncology, Inc.
Citius Oncology, Inc. (CTOR) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · CTOR · as of Jun 9, 2026
Activity summary
Buy transactions
0
P-Purchase only
Sell transactions
0
12 Months
Buy/Sell ratio
0.00
Buy/Sell (by trades)
Overall sentiment
Citius Oncology, Inc. insiders have shown mixed buying and selling activity over the past 12 Months.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 9, 2026
CTOR insider buying and selling by quarter
CTOR insider selling · CTOR insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 9, 2026
Active insiders
Most active in past 12 months · CTOR ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
CTOR executive sell shares · CTOR board member insider trading · CTOR insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Sep 19, 2025 | HOLUBIAK MYRON Z Secretary · Director | Award | 850,000 | — | Form 4 |
| Sep 19, 2025 | HOLUBIAK MYRON Z Secretary · Director | Award | 100,000 | — | Form 4 |
| Sep 19, 2025 | Smith Robert Joseph Director | Award | 300,000 | — | Form 4 |
| Sep 19, 2025 | Mazur Leonard L CEO · Director | Award | 1,700,000 | — | Form 4 |
| Sep 19, 2025 | Webb Carol Director | Award | 300,000 | — | Form 4 |
| Sep 19, 2025 | Czuczman Myron Chief Medical Officer | Award | 825,000 | — | Form 4 |
| Sep 19, 2025 | MCGRATH DENNIS M Director | Award | 300,000 | — | Form 4 |
| Sep 19, 2025 | Bartushak Jaime CFO | Award | 825,000 | — | Form 4 |
| Sep 19, 2025 | Mayersohn Joel David Director | Award | 300,000 | — | Form 4 |
| Sep 19, 2025 | Dutia Suren G Director | Award | 300,000 | — | Form 4 |
| Sep 19, 2025 | Holuka Eugene Myron Director | Award | 300,000 | — | Form 4 |
| Jul 28, 2025 | Mayersohn Joel David Director | Other | 21,228 | — | Form 4 |
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About CTOR insider trading
CTOR insider trades
Citius Oncology, Inc. (CTOR) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including HOLUBIAK MYRON Z (Secretary · Director), Mayersohn Joel David (Director), Smith Robert Joseph (Director). Over the past 12 months, 5 insiders have filed transactions with the SEC. CTOR insiders have been mixed buying and selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Citius Oncology, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
CTOR insider trading · 5 questionsThe insiders of Citius Oncology, Inc. (CTOR) include executives and directors such as HOLUBIAK MYRON Z (Secretary · Director), Mayersohn Joel David (Director), Smith Robert Joseph (Director), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026